Skip to main content

Editorial label review

Alloy side effects: mood swings

Primary formulary: Estradiol (oral and patch) + oral micronized progesterone; oxybutynin ER for vasomotor symptoms

Quick answer

Mood swings shows up on the FDA labels for the active ingredients Alloy prescribes — Estradiol (oral and patch) + oral micronized progesterone. This page walks through the labelled frequency ranges, what to watch for, and when to call your clinician.

What Alloy prescribes and why it matters for mood swings

Alloy prescribes FDA-approved bioidentical estradiol and oral micronized progesterone, plus oxybutynin ER as a non-hormonal option for vasomotor symptoms. Because Alloy prescribes FDA-approved active ingredients, the labelled adverse-reaction tables from those medications describe the frequencies you should expect. Mood-disturbance entries appear on estradiol, progesterone, and paroxetine PIL surfaces.

Common label-level side effects

Sourced from Section 6 (Adverse Reactions) of each FDA-approved PIL.

  • "Mood disturbance" and "emotional lability" are listed at 2–6% on estradiol-progestin combination PIL Section 6 tables
  • Prometrium PIL Section 5.6 requires evaluation for depression, mood change, or irritability during therapy
  • Label narrative notes mood swings often peak in the first 2–3 cycles before stabilising — not a comparative efficacy claim

Serious label-level warnings

Drawn from Section 5 (Warnings and Precautions) of the FDA-approved PILs — including the estradiol boxed warning where applicable.

  • Severe or persistent mood change — the Prometrium label instructs discontinuation if serious depression recurs
  • New suicidal thoughts on paroxetine — FDA class boxed warning applies to Brisdelle

When to contact your clinician

Contact your clinician same-day if mood change is severe, persistent, or paired with any suicidal thoughts — both progesterone and paroxetine labels require urgent review.

Call 911 if you develop chest pain, one-sided weakness, sudden severe headache, vision or speech change, or shortness of breath — per the estradiol PIL boxed warning for cardiovascular events.

What to ask your provider

  • “Which SKU in the Alloy formulary am I on, and what is its labelled frequency for mood swings?”
  • “Is my mood swingslikely a labelled adverse reaction, or something separate that needs its own workup?”
  • “Would a different delivery route (patch vs. pill, oral vs. transdermal) change my expected frequency?”
  • “What is the plan if mood swingsdoes not settle within 2–3 cycles?”

Frequently asked questions

How often does mood swings happen on Alloy?
Alloy's primary regimen — Estradiol (oral and patch) + oral micronized progesterone; oxybutynin ER for vasomotor symptoms — carries the FDA-labelled adverse-reaction frequencies for mood swings described on this page. Ranges vary from < 1% to 45% depending on the specific active ingredient and delivery route. See the sources block for the exact PIL tables.
When should I stop Alloy because of mood swings?
Talk to your clinician immediately if you meet any of the "when to contact" criteria on this page — most estradiol PIL Section 5 warnings require prompt reassessment. Do not stop hormone therapy without medical input; abrupt discontinuation can trigger rebound symptoms.
Is mood swings on the FDA label for Alloy's medications?
Mood-disturbance entries appear on estradiol, progesterone, and paroxetine PIL surfaces.
Is mood swings caused by menopause itself?
Mood swings can appear during the menopause transition for reasons unrelated to hormone therapy. Our /does-menopause-cause/mood-swings explainer covers what the underlying biology is and how clinicians disentangle the transition from the treatment.

Sources

  1. FDAFDA-approved label — Estrace (estradiol) via DailyMed
  2. FDAFDA-approved label — Vivelle-Dot (estradiol transdermal) via DailyMed
  3. FDAFDA-approved label — Prometrium (micronized progesterone) via DailyMed